Am J Transplant, Volume 19, Suppl 3 Archives - Page 119 of 214 - ATC Abstracts

2019 American Transplant Congress
Gait Speed Predicts Kidney Transplant Candidate Mortality
M. N. Harhay¹, K. Ranganna¹, L. B. Levin Mizrahi¹, G. Xiao², G. Malat², S. Guy², D. Reich², P. P. Reese³
¹Medicine, Drexel University College of Medicine, Philadelphia, PA, ²Surgery, Drexel University College of Medicine, Philadelphia, PA, ³Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA
*Purpose: Waiting list mortality is increasingly scrutinized as a metric of transplant center quality. It is unknown if gait speed assessments may augment physician evaluations…
2019 American Transplant Congress
High Health Care Utilizers in Kidney Transplantation: Do You Know Your Frequent Flyers?
E. Weeda¹, Z. Su², D. Taber³, J. Bian², T. A. Morinelli⁴, N. A. Pilch⁵, P. D. Mauldin², D. A. DuBay⁴
¹Department of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina`, Charleston, SC, ²General Internal Medicine and Geriatrics, Medical University of South Carolina`, Charleston, SC, ³Surgery and Ralph H. Johnson VAMC, Medical University of South Carolina`, Charleston, SC, ⁴Surgery, Medical University of South Carolina`, Charleston, SC, ⁵Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina`, Charleston, SC
*Purpose: To assess high hospital inpatient [IP] admissions and emergency department [ED] utilization within a 9-month period after kidney transplantation in order to identify potential…
2019 American Transplant Congress
Organ Donation Rates And Transplantation Activity Comparing Opt-out Versus Opt-in Systems: A Cross-sectional Study Of Oecd Countries
A. Arshad¹, M. Babiker², B. Anderson², A. Sharif²
¹University of Birmingham, Birmingham, United Kingdom, ²Queen Elizabeth Hospital, Department of Nephrology and Transplantation, Birmingham, United Kingdom
*Purpose: The aim of this study was to compare organ donation and transplantation rates between opt-out versus opt-in countries to investigate for any significant difference…
2019 American Transplant Congress
Multicenter Experience Evaluating Outcomes of HCV-Seropositive Donors to HCV-Seronegative Recipients Liver Transplantation
K. Wijarnpreecha¹, B. Aqel², S. Pungpapong¹, C. Taner³, K. Reddy⁴, M. Leise⁵, R. Dickson²
¹Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, ²Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, ³Transplant, Mayo Clinic, Jacksonville, FL, ⁴Transplant and Hepatobiliary Surgery, Mayo Clinic, Scottsdale, AZ, ⁵Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
*Purpose: Grafts from hepatitis C virus (HCV)-seropositive donors can now be considered for liver transplant (LT) due to the advent of direct-acting antiviral agents (DAA).…
2019 American Transplant Congress
CXCL12-CXCR4-Mediated Chemotaxis is a Potential Mechanism for Monocyte Recruitment in Ischemia-Reperfusion Injury in Orthotopic Liver Transplant Patients
A. Q. Terry¹, R. A. Sosa¹, B. V. Naini¹, V. Groysberg¹, F. M. Kaldas², R. W. Busuttil², D. Gjertson¹, J. Kupiec-Weglinski², E. F. Reed¹
¹Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, ²Surgery, University of California, Los Angeles, Los Angeles, CA
*Purpose: Ischemia-reperfusion injury (IRI) elicits cellular damage which lowers allograft survival in orthotopic liver transplant (OLT) patients. Damage-associated molecular patterns, such as high-mobility group box…
2019 American Transplant Congress
Excellent Outcome in African-American (AA), Type 1 and Type 2 Diabetic Recipients after Simultaneous Pancreas and Kidney Transplantation (SPK)
A. Gruessner, S. Saggi, R. W. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: African-American recipients (AA) are considered a high risk group for organ transplantation. As outcomes after pancreas transplantation have significantly improved, the number of transplants…
2019 American Transplant Congress
Risk Predictive Strategy to Expand Pancreas Donor Selection
J. W. Mensink¹, K. M. Ooms - de Vries², V. A. Huurman¹, R. A. Pol³, I. P. Alwayn¹, A. E. Braat¹
¹Department of Surgery; Division of Transplantation, Leiden University Medical Center, Leiden, Netherlands, ²Dutch Transplant Foundation, Leiden, Netherlands, ³Department of Surgery; Division of Transplantation, University Medical Center Groningen, Groningen, Netherlands
*Purpose: The discrepancy between the number of patients on the waiting list and the number of donor pancreata for transplantation needs extension of accepting criteria…
2019 American Transplant Congress
Outcomes of Portal Vein Extension Grafts in Pancreas Transplantation: A Single-Centre Analysis
S. R. Punjala, B. L. Phillips, N. Karydis, F. Calder, C. J. Callaghan
Department of Nephrology, Renal Transplantation and Urology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom
*Purpose: Surgical dogma suggests that portal vein extension grafts (PVEGs) in pancreas transplantation should be strenuously avoided, though the evidence-base is lacking. In our unit,…
2019 American Transplant Congress
Impact of an mHealth, Electronic Pillbox Intervention on Tacrolimus Variability in Kidney Transplantation: Results of a Prospective Randomized Clinical Trial
J. W. McGillicuddy, L. Sox, J. Chandler, F. Treiber, D. Taber
Medical University of South Carolina, Charleston, SC
*Purpose: Medication non-adherence (MNA) is a major risk factor and leading cause of late allograft loss in kidney transplant (KTX) recipients. Tacrolimus trough concentration variability,…
2019 American Transplant Congress
Characteristics And Outcomes Of Early Onset Cancers After Kidney Transplantation
W. Lim¹, E. Au², A. Krishnan¹, G. Wong²
¹Sir Charles Gairdner Hospital, Perth, Australia, ²University of Sydney & Westmead Hospital, Sydney, Australia
*Purpose: Incident cancers developing after kidney transplantation are associated with significant morbidity and mortality and therefore age-appropriate cancer screening is recommended to identify asymptomatic cancers…